There has been a steady decline in death rates among children and adolescent patients diagnosed with cancer (ages 1 to 19 years), minus gender or racial disparity, between 1999 and 2014, according to a new report from the National Center for Health Statistics.
There has been a steady decline in death rates among children and adolescent patients diagnosed with cancer, without gender or racial disparity, between 1999 and 2014, according to a new report released by the National Vital Statistics System of the National Center for Health Statistics. A significant finding of the report is that brain cancer has replaced leukemia as the leading cause of cancer-related death.
Pediatric cancers have seen a steady decline in mortality over the past decade, despite a slow increase in incidence of certain cancer types. For the current report, the researchers evaluated cancer death rates for children between ages 1 and 19 years for the period between 1999 and 2014. They compared death rates for both male and females, as well as white and black children and adolescents. The following are key findings from the report for that period:
Reference
Curtin SC, Miniño AM, Anderson RN. Declines in cancer death rates among children and adolescents in the United States, 1999—2014. NCHS data brief, no 257. Hyattsville, MD: National Center for Health Statistics; 2016.
MINT Trial 26-Week Data Show Inebilizumab for gMG Is Effective and Safe
April 1st 2025These are data to week 26 on the monoclonal antibody and antineoplastic agent; data out to week 52 of the MINT trial will be presented in a late-breaking oral session at the upcoming American Academy of Neurology Annual Meeting.
Read More
FDA Approves Cabozantinib for Advanced Pancreatic Neuroendocrine Tumors
March 26th 2025With strong progression-free survival benefits demonstrated in the CABINET trial and updates to National Comprehensive Cancer Network guidelines, this approval reinforces cabozantinib’s role in improving outcomes for patients facing these challenging cancers.
Read More